Remove Marketing Remove Partnerships Remove Safety
article thumbnail

U.S FDA Approves Mirdametinib (Gomekli, SpringWorks) for Adult and Pediatric Patients With NF1-PN

The Dermatology Digest

It was very encouraging in the ReNeu trial to see that Gomekli provided deep and durable responses, with a manageable safety profile that enabled patients to stay on therapy. Gomekli demonstrated a manageable safety and tolerability profile. Every treatment approval is hard-won, built on research, persistence, and partnership.

article thumbnail

FDA Green Lights New Stelara Biosimilar

The Dermatology Digest

Under the strategic partnership between Teva and Alvotech, Teva is responsible for the exclusive commercialization of Selarsdi in the United States. Market Access at Teva, in a news release. Bringing Selarsdi to market in the U.S. says Thomas Rainey, Senior Vice President, U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

TDD Industry News and Views: Weekly Updates on Comings, Goings, and Other Happenings in Dermatology

The Dermatology Digest

via a strategic partnership with BENEV Company, Inc. The two companies will collaborate in sales, marketing, education, and research. market share within three years. market,” says Ethan Min, CEO of BENEV, in a news release. .” market,” says Ethan Min, CEO of BENEV, in a news release. “We Hugel Inc.’s

article thumbnail

Learn Laser Hair Removal and IPL 

Lipgloss and Aftershave

Unlike large laser companies that spend millions on marketing with big events, influencer partnerships, and doctor endorsements, we avoid these costly strategies, which often contribute to significant price markups. Question Are all of your lasers good for all Fitzpatricks?

article thumbnail

Arch Amenities’ Catherine Warren on technology & creating memorable experiences.

Spa Executive

Catherine Warren is Vice President of Strategic Partnerships at Arch Amenities Group, a provider of comprehensive amenity management and consulting services for hotels, residential complexes, and commercial real estate.

article thumbnail

Biosimilar News: Stada, Alvotech Launch the First Ustekinumab Biosimilar Across Europe

The Dermatology Digest

Launching Uzpruvo at the earliest opportunity in Europe’s largest pharmaceutical markets, promotes access by creating competition,” says STADA CEO Peter Goldschmidt in a news release. We are delighted at the launch of Uzpruvo in Europe and to be first-to-market,” adds Robert Wessman, Chief Executive Officer of Alvotech.

article thumbnail

All about finding the best third-party cosmetic manufacturer in India

Cosmetify

Some of these benefits are: Expertise and resources: Third-party manufacturers are experts who have state-of-the-art facilities, experienced, qualified, and knowledgeable staff, and technical and market expertise to carry out production with ease. This includes adhering to product safety, labeling, and packaging regulations.